Ten artyku szczegowo analizuje nauk stojc za t hipotez i jej praktyczne implikacje
GLP-1 drugs are a class of medications that help lower blood sugar and promote weight loss by mimicking the gut hormone glucagon-like peptide-1
priority program SPP1937 Innate lymphoid cells, grants SCHL 615/1-1 and 1-2 to US and grants BO 996/5-1 and 5-2 to CB
Now I can totally relate. Ohio metabolic specialist Dr Paul Kolodzik (also board-certified in addiction medicine) told insider.com that while more research is needed on the drugs potential use as a treatment for alcohol-use disorder, it could be the next big thing in addiction management, certainly related to alcohol. Dr Kolodzik confirmed some of his weight-loss patients say they no longer experience alcohol cravings while on semaglutide, and noted GLP-1 receptor agonists like semaglutide increase satiety, both in your stomach and in your head which can suppress alcohol cravings as well as food cravings
Some people feel improvement within 12 to 24 hours, but maximum benefit can take several days
liraglutide (Saxenda) and semaglutide (Wegovy), which are GLP-1 receptor agonists with no clinically significant pharmacokinetic interactions with SSRIs according to their Summary of Product Characteristics (SmPC)